Diverse mechanisms evolved by DNA viruses to inhibit early host defenses

Critical Reviews in Biochemistry and Molecular Biology

Volumn 51, Issue 6, 2016, Pages 452-481

  Crow, Marni S ^a   Lum, Krystal K ^a   Sheng, Xinlei ^a   Song, Bokai ^a   Cristea, Ileana M ^a  

^a PRINCETON UNIVERSITY   (United States)

Author keywords

apoptosis; innate immunity; intrinsic immunity; post translational modification; proteasomal degradation; Viral immune evasion; viral mimicry; virus host interactions

Indexed keywords

CYTOKINE; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLAMMASOME; INTERFERON; MICRORNA; PROTEASOME; VIRAL PROTEIN; VIRUS RNA; DNA VIRUS; MESSENGER RNA;

APOPTOSIS; DNA VIRUS; GENETIC TRANSCRIPTION; HERPESVIRIDAE; HOST RESISTANCE; HUMAN; INNATE IMMUNITY; MOLECULAR MIMICRY; NONHUMAN; POXVIRIDAE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROCESSING; REVIEW; RNA STABILITY; TRANSCRIPTION INITIATION; TRANSLATION INITIATION; TRANSLATION REGULATION; ANIMAL; CELLULAR IMMUNITY; DNA VIRUS INFECTION; GENE EXPRESSION REGULATION; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; METABOLISM; PATHOLOGY; PHYSIOLOGY; VIRUS REPLICATION;

ANIMALS; APOPTOSIS; DNA VIRUS INFECTIONS; DNA VIRUSES; GENE EXPRESSION REGULATION; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, INNATE; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOLYSIS; RNA, MESSENGER; VIRUS REPLICATION;

EID: 84994000405     PISSN: 10409238     EISSN: 15497798     Source Type: Journal    
DOI: 10.1080/10409238.2016.1226250     Document Type: Review

References (280)

1. J.M.Adams, S.Cory (1998). The Bcl-2 protein family:arbiters of cell survival. Science 281:1322–6.
2. J.-H.Ahn, G.S.Hayward (2000). Disruption of PML-associated nuclear bodies by IE1 correlates with efficient early stages of viral gene expression and DNA replication in human cytomegalovirus infection. Virology 274:39–55.
3. S.Akira, K.Takeda, T.Kaisho (2001). Toll-like receptors:critical proteins linking innate and acquired immunity. Nat Immunol 2:675–80.
4. S.Akira, S.Uematsu, O.Takeuchi (2006). Pathogen recognition and innate immunity. Cell 124:783–801.
5. S.Albert, J.Baldwin (1996). THE NF-κB AND IκB PROTEINS:new discoveries and insights. Annu Rev Immunol 14:649–81.
6. L.Amsler, M.C.Verweij, V.R.DeFilippis (2013). The tiers and dimensions of evasion of the type I interferon response by human cytomegalovirus. J Mol Biol 425:4857–71.
7. C.Aresté, M.Mutocheluh, D.J.Blackbourn (2009). Identification of caspase-mediated decay of interferon regulatory factor-3, exploited by a Kaposi sarcoma-associated herpesvirus immunoregulatory protein. J Biol Chem 284:23272–85.
8. M.Baron, J.L.Davignon (2008). Inhibition of IFN-induced STAT1 tyrosine phosphorylation by human CMV is mediated by SHP2. J Immunol 181:5530–6.
9. M.Barry, G.McFadden (1998). Apoptosis regulators from DNA viruses. Curr Opin Immunol 10:422–30.
10. P.S.Beisser, D.Verzijl, Y.K.Gruijthuijsen, et al. (2005). The Epstein–Barr virus BILF1 gene encodes a G protein-coupled receptor that inhibits phosphorylation of RNA-dependent protein kinase. J Virol 79:441–9.
11. S.M.Best, J.F.Shelton, J.M.Pompey, et al. (2003). Caspase cleavage of the nonstructural protein NS1 mediates replication of Aleutian mink disease parvovirus. J Virol 77:5305–12.
12. S.M.Best, J.B.Wolfinbarger, M.E.Bloom (2002). Caspase activation is required for permissive replication of aleutian mink disease parvovirus in vitro. Virology 292:224–34.
13. D.K.Bideshi, Y.Tan, Y.Bigot, B.A.Federici (2005). A viral caspase contributes to modified apoptosis for virus transmission. Genes Dev 19:1416–21.
14. T.M.Bigley, J.M.Reitsma, S.P.Mirza, S.S.Terhune (2013). Human cytomegalovirus pUL97 regulates the viral major immediate early promoter by phosphorylation-mediated disruption of histone deacetylase 1 binding. J Virol 87:7393–408.
15. B.Bodaghi, T.R.Jones, D.Zipeto, et al. (1998). Chemokine sequestration by viral chemoreceptors as a novel viral escape strategy:withdrawal of chemokines from the environment of cytomegalovirus-infected cells. J Exp Med 188:855–66.
16. I.W.Boss, R.Renne (2010). Viral miRNAs:tools for immune evasion. Curr Opin Microbiol 13:540–5.
17. C.Boutell, D.Cuchet-Lourenco, E.Vanni, et al. (2011). A viral ubiquitin ligase has substrate preferential SUMO targeted ubiquitin ligase activity that counteracts intrinsic antiviral defense. PLoS Pathog 7:e1002245.
18. C.Boutell, A.Orr, R.D.Everett (2003). PML residue lysine 160 is required for the degradation of PML induced by herpes simplex virus type 1 regulatory protein ICP0. J Virol 77:8686–94.
19. C.Boutell, S.Sadis, R.D.Everett (2002). Herpes simplex virus type 1 immediate-early protein ICP0 and its isolated RING finger domain act as ubiquitin E3 ligases in vitro. J Virol 76:841–50.
20. A.G.Bowie, L.Unterholzner (2008). Viral evasion and subversion of pattern-recognition receptor signaling. Nat Rev Immunol 8:911–22.
21. J.Boyer, K.Rohleder, G.Ketner (1999). Adenovirus E4 34k and E4 11k inhibit double strand break repair and are physically associated with the cellular DNA-dependent protein kinase. Virology 263:307–12.
22. A.Brestovitsky, K.Nebenzahl-Sharon, P.Kechker, et al. (2016). The adenovirus E4orf4 protein provides a novel mechanism for inhibition of the DNA damage response. PLoS Pathog 12:e1005420.
23. A.Brun, C.Rivas, M.Esteban, et al. (1996). African swine fever virus gene A179L, a viral homolog of bcl-2, protects cells from programed cell death. Virology 225:227–30.
24. L.Burýšek, P.M.Pitha (2001). Latently expressed human herpesvirus 8-encoded interferon regulatory factor 2 inhibits double-stranded RNA-activated protein kinase. J Virol 75:2345–52.
25. L.Burýšek, W.-S.Yeow, B.Lubyová, et al. (1999). Functional analysis of human herpesvirus 8-encoded viral interferon regulatory factor 1 and its association with cellular interferon regulatory factors and p300. J Virol 73:7334–42.
26. M.R.Chacon, F.Almazan, M.L.Nogal, et al. (1995). The African swine fever virus IAP homolog is a late structural polypeptide. Virology 214:670–4.
27. F.K.M.Chan, J.Shisler, J.G.Bixby, et al. (2003). A role for tumor necrosis factor receptor-2 and receptor-interacting protein in programed necrosis and antiviral responses. J Biol Chem 278:51613–21.
28. W.L.W.Chang, P.A.Barry, R.Szubin, et al. (2009). Human cytomegalovirus suppresses type I interferon secretion by plasmacytoid dendritic cells through its interleukin 10 homolog. Virology 390:330–7.
29. D.T.Chao, S.J.Korsmeyer (1998). BCL-2 family:regulators of cell death. Annu Rev Immunol 16:395–419.
30. M.Chatterjee, J.Osborne, G.Bestetti, et al. (2002). Viral IL-6-induced cell proliferation and immune evasion of interferon activity. Science 298:1432–5.
31. L.Chen, W.Fischle, E.Verdin, W.C.Greene (2001). Duration of nuclear NF-kappaB action regulated by reversible acetylation. Science 293:1653–7.
32. L.F.Chen, W.C.Greene (2004). Shaping the nuclear action of NF-kappaB. Nat Rev Mol Cell Biol 5:392–401.
33. R.A.J.Chen, G.Ryzhakov, S.Cooray, et al. (2008). Inhibition of I kappa B kinase by vaccinia virus virulence factor b14. PLoS Pathog 4:e22.
34. K.C.Chin, P.Cresswell (2001). Viperin (cig5), an IFN-inducible antiviral protein directly induced by human cytomegalovirus. Proc Natl Acad Sci USA 98:15125–30.
35. S.H.Chiou, Y.P.Yang, J.C.Lin, et al. (2006). The immediate early 2 protein of human cytomegalovirus (HCMV) mediates the apoptotic control in HCMV retinitis through up-regulation of the cellular FLICE-inhibitory protein expression. J Immunol 177:6199–206.
36. Y.Cho, S.Challa, D.Moquin, et al. (2009). Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programed necrosis and virus-induced inflammation. Cell 137:1112–23.
37. D.-C.Chow, X.-L.He, A.L.Snow, et al. (2001). Structure of an extracellular gp130 cytokine receptor signaling complex. Science 291:2150–5.
38. G.M.Cohen (1997). Caspases:the executioners of apoptosis. Biochem J 326:1–16.
39. T.Compton, E.A.Kurt-Jones, K.W.Boehme, et al. (2003). Human cytomegalovirus activates inflammatory cytokine responses via CD14 and toll-like receptor 2. J Virol 77:4588–96.
40. S.Cory, A.Strasser, T.Jacks, et al. (1994). Enhanced cell survival and tumorigenesis. Cold Spring Harb Symp Quant Biol 59:365–75.
41. S.Covarrubias, M.M.Gaglia, G.R.Kumar, et al. (2011). Coordinated destruction of cellular messages in translation complexes by the gammaherpesvirus host shutoff factor and the mammalian exonuclease Xrn1. PLoS Pathog 7:1002339
42. S.Covarrubias, J.M.Richner, K.Clyde, et al. (2009). Host shutoff is a conserved phenotype of gammaherpesvirus infection and is orchestrated exclusively from the cytoplasm. J Virol 83:9554–66.
43. I.M.Cristea, N.J.Moorman, S.S.Terhune, et al. (2010). Human cytomegalovirus pUL83 stimulates activity of the viral immediate-early promoter through its interaction with the cellular IFI16 protein. J Virol 84:7803–14.
44. M.Crompton (1999). The mitochondrial permeability transition pore and its role in cell death. Biochem J 341:233–49.
45. M.S.Crow, A.Javitt, I.M.Cristea (2015). A proteomics perspective on viral DNA sensors in host defense and viral immune evasion mechanisms. J Mol Biol 427:1995–2012.
46. D.Cuchet-Lourenço, G.Anderson, E.Sloan, et al. (2013). The viral ubiquitin ligase ICP0 is neither sufficient nor necessary for degradation of the cellular DNA sensor IFI16 during herpes simplex virus 1 infection. J Virol 87:13422–32.
47. D.Cuchet-Lourenço, E.Vanni, M.Glass, et al. (2012). Herpes simplex virus 1 ubiquitin ligase ICP0 interacts with PML isoform I and induces its SUMO-independent degradation. J Virol 86:11209–22.
48. M.V.Davies, H.W.Chang, B.L.Jacobs, R.J.Kaufman (1993). The E3l and K3l vaccinia virus gene-products stimulate translation through inhibition of the double-stranded Rna-dependent protein-kinase by different mechanisms. J Virol 67:1688–92.
49. G.S.Dbaibo, Y.A.Hannun (1998). Cytokine response modifier A (CrmA):a strategically deployed viral weapon. Clin Immunol Immunopathol 86:134–40.
50. T.Derfuss, H.Fickenscher, M.S.Kraft, et al. (1998). Antiapoptotic activity of the herpesvirus saimiri-encoded Bcl-2 homolog:stabilization of mitochondria and inhibition of caspase-3-like activity. J Virol 72:5897–904.
51. T.Dimitrov, P.Krajcsi, T.W.Hermiston, et al. (1997). Adenovirus E3-10.4K/14.5K protein complex inhibits tumor necrosis factor-induced translocation of cytosolic phospholipase A2 to membranes. J Virol 71:2830–7.
52. C.Dinarello, D.Novick, S.Kim, G.Kaplanski (2013). Interleukin-18 and interleukin-18 binding protein. Front Immunol 4:289
53. B.A.Diner, T.Li, T.M.Greco, et al. (2015). The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. Mol Syst Biol 11:787.
54. B.A.Diner, K.K.Lum, A.Javitt, I.M.Cristea (2015). Interactions of the antiviral factor interferon gamma-inducible protein 16 (IFI16) mediate immune signaling and herpes simplex virus-1 immunosuppression. Mol Cell Proteomics 14:2341–56.
55. T.Dobner, N.Horikoshi, S.Rubenwolf, T.Shenk (1996). Blockage by adenovirus E4orf6 of transcriptional activation by the p53 tumor suppressor. Science 272:1470–3.
56. V.Doucas, A.M.Ishov, A.Romo, et al. (1996). Adenovirus replication is coupled with the dynamic properties of the PML nuclear structure. Genes Dev 10:196–207.
57. R.J.Duerst, L.A.Morrison (2004). Herpes simplex virus 2 virion host shutoff protein interferes with type I interferon production and responsiveness. Virology 322:158–67.
58. E.Dzananovic, T.R.Patel, G.Chojnowski, et al. (2014). Solution conformation of adenovirus virus associated RNA-I and its interaction with PKR. J Struct Biol 185:48–57.
59. M.M.Elgadi, C.E.Hayes, J.R.Smiley (1999). The herpes simplex virus vhs protein induces endoribonucleolytic cleavage of target RNAs in cell extracts. J Virol 73:7153–64.
60. M.Enari, H.Sakahira, H.Yokoyama, et al. (1998). A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391:43–50.
61. R.D.Everett, M.K.Chelbi-Alix (2007). PML and PML nuclear bodies:implications in antiviral defense. Biochimie 89:819–30.
62. R.D.Everett, S.Rechter, P.Papior, et al. (2006). PML contributes to a cellular mechanism of repression of herpes simplex virus type 1 infection that is inactivated by ICP0. J Virol 80:7995–8005.
63. D.N.Everly, P.H.Feng, I.S.Mian, G.S.Read (2002). mRNA degradation by the virion host shutoff (Vhs) protein of herpes simplex virus:genetic and biochemical evidence that Vhs is a nuclease. J Virol 76:8560–71.
64. B.J.Ferguson, D.S.Mansur, N.E.Peters, et al. (2012). DNA-PK is a DNA sensor for IRF-3-dependent innate immunity. Elife 2012;1:e00047
65. R.Ferrari, D.Gou, G.Jawdekar, et al. (2014). Adenovirus small E1A employs the lysine acetylases p300/CBP and tumor suppressor Rb to repress select host genes and promote productive virus infection. Cell Host Microbe 16:663–76.
66. K.A.Fitzgerald, S.M.McWhirter, K.L.Faia, et al. (2003). IKK epsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol 4:491–6.
67. S.B.Fleming, C.A.McCaughan, A.E.Andrews, et al. (1997). A homolog of interleukin-10 is encoded by the poxvirus or virus. J Virol 71:4857–61.
68. G.J.Fonseca, G.Thillainadesan, A.F.Yousef, et al. (2012). Adenovirus evasion of interferon-mediated innate immunity by direct antagonism of a cellular histone posttranslational modification. Cell Host Microbe 11:597–606.
69. F.Full, D.Jungnickl, N.Reuter, et al. (2014). Kaposi's sarcoma associated herpesvirus tegument protein ORF75 is essential for viral lytic replication and plays a critical role in the antagonization of ND10-instituted intrinsic immunity. PLoS Pathog 10:e1003863.
70. F.Full, N.Reuter, K.Zielke, et al. (2012). Herpesvirus saimiri antagonizes nuclear domain 10-instituted intrinsic immunity via an ORF3-mediated selective degradation of cellular protein Sp100. J Virol 86:3541–53.
71. M.M.Gaglia, S.Covarrubias, W.Wong, B.A.Glaunsinger (2012). A common strategy for host RNA degradation by divergent viruses. J Virol 86:9527–30.
72. J.L.Gao, P.M.Murphy (1994). Human cytomegalovirus open reading frame US28 encodes a functional beta chemokine receptor. J Biol Chem 269:28539–42.
73. B.Glaunsinger, D.Ganem (2004). Lytic KSHV infection inhibits host gene expression by accelerating global mRNA turnover. Mol Cell 13:713–23.
74. J.N.Glickman, J.G.Howe, J.A.Steitz (1988). Structural-analyses of Eber1 and Eber2 ribonucleoprotein-particles present in Epstein–Barr virus-infected cells. J Virol 62:902–11.
75. D.Glykofrydes, H.Niphuis, E.M.Kuhn, et al. (2000). Herpesvirus saimiri vFLIP provides an antiapoptotic function but is not essential for viral replication, transformation, or pathogenicity. J Virol 74:11919–27.
76. N.F.Go, B.E.Castle, R.Barrett, et al. (1990). Interleukin 10, a novel B cell stimulatory factor:unresponsiveness of X chromosome-linked immunodeficiency B cells. J Exp Med 172:1625–31.
77. V.S.Goldmacher (2002). vMIA, a viral inhibitor of apoptosis targeting mitochondria. Biochimie 84:177–85.
78. R.Gonzalez, W.Huang, R.Finnen, et al. (2006). Adenovirus E1B 55-kilodalton protein is required for both regulation of mRNA export and efficient entry into the late phase of infection in normal human fibroblasts. J Virol 80:964–74.
79. R.J.Grand, K.Schmeiser, E.M.Gordon, et al. (2002). Caspase-mediated cleavage of adenovirus early region 1A proteins. Virology 301:255–71.
80. D.J.Granville, C.M.Carthy, D.Yang, et al. (1998). Interaction of viral proteins with host cell death machinery. Cell Death Differ 5:653–9.
81. A.Griffiths, D.M.Coen (2005). An unusual internal ribosome entry site in the herpes simplex virus thymidine kinase gene. P Natl Acad Sci USA 102:9667–72.
82. S.Guerra, A.Caceres, K.P.Knobeloch, et al. (2008). Vaccinia virus E3 protein prevents the antiviral action of ISG15. PLoS Pathog 4:e100009.
83. A.J.Guise, H.G.Budayeva, B.A.Diner, I.M.Cristea (2013). Histone deacetylases in herpesvirus replication and virus-stimulated host defense. Viruses 5:1607–32.
84. D.M.Haig, J.Thomson, C.J.McInnes, et al. (2002). A comparison of the anti-inflammatory and immuno-stimulatory activities of orf virus and ovine interleukin-10. Virus Res 90:303–16.
85. O.Haller, G.Kochs, F.Weber (2006). The interferon response circuit:induction and suppression by pathogenic viruses. Virology 344:119–30.
86. F.Han, X.B.Zhang (2006). Internal initiation of mRNA translation in insect cell mediated by an internal ribosome entry site (IRES) from shrimp white spot syndrome virus (WSSV). Biochem Biophys Res Co 344:893–9.
87. J.N.Harada, A.Shevchenko, A.Shevchenko, et al. (2002). Analysis of the adenovirus E1B-55K-anchored proteome reveals its link to ubiquitination machinery. J Virol 76:9194–206.
88. W.R.Hardy, R.M.Sandri-Goldin (1994). Herpes simplex virus inhibits host cell splicing, and regulatory protein ICP27 is required for this effect. J Virol 68:7790–9.
89. D.Harman (1992). Role of free radicals in aging and disease. Ann N Y Acad Sci 673:126–41.
90. M.T.Harte, I.R.Haga, G.Maloney, et al. (2003). The poxvirus protein A52R targets toll-like receptor signaling complexes to suppress host defense. J Exp Med 197:343–51.
91. B.Hoffman, D.A.Liebermann (2008). Apoptotic signaling by c-MYC. Oncogene 27:6462–72.
92. J.R.Hogg (2016). Viral evasion and manipulation of host RNA quality control pathways. J Virol 90:7010–18.
93. G.A.Horwitz, K.Zhang, M.A.McBrian, et al. (2008). Adenovirus small e1a alters global patterns of histone modification. Science (New York, NY) 321:1084–5.
94. H.Hsu, J.Xiong, D.V.Goeddel (1995). The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation. Cell 81:495–504.
95. F.Q.Hu, C.A.Smith, D.J.Pickup (1994). Cowpox virus contains two copies of an early gene encoding a soluble secreted form of the type II TNF receptor. Virology 204:343–56.
96. S.M.Hu, C.Vincenz, M.Buller, V.M.Dixit (1997). A novel family of viral death effector domain-containing molecules that inhibit both CD-95-and tumor necrosis factor receptor-1-induced apoptosis. J Biol Chem 272:9621–4.
97. J.M.Huibregtse, M.Scheffner, P.M.Howley (1991). A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. EMBO J 10:4129–35.
98. J.Hwang, R.F.Kalejta (2007). Proteasome-dependent, ubiquitin-independent degradation of Daxx by the viral pp71 protein in human cytomegalovirus-infected cells. Virology 367:334–8.
99. P.P.John Hiscott, P.Genin, H.Nguyen, et al. (1999). Triggering the interferon response:the role of IRF-3 transcription factor. J Interferon Cytokine Res 19:1–13.
100. J.B.Johnston, J.W.Barrett, S.H.Nazarian, et al. (2005). A poxvirus-encoded pyrin domain protein interacts with ASC-1 to inhibit host inflammatory and apoptotic responses to infection. Immunity 23:587–98.
101. B.C.Jones, N.J.Logsdon, K.Josephson, et al. (2002). Crystal structure of human cytomegalovirus IL-10 bound to soluble human IL-10R1. Proc Natl Acad Sci 99:9404–9.
102. C.H.Joo, Y.C.Shin, M.Gack, et al. (2007). Inhibition of interferon regulatory factor 7 (IRF7)-mediated interferon signal transduction by the Kaposi's sarcoma-associated herpesvirus viral IRF homolog vIRF3. J Virol 81:8282–92.
103. W.J.Kaiser, J.W.Upton, E.S.Mocarski (2013). Viral modulation of programed necrosis. Curr Opin Virol 3:296–306.
104. R.F.Kalejta, T.Shenk (2003). Proteasome-dependent, ubiquitin-independent degradation of the Rb family of tumor suppressors by the human cytomegalovirus pp71 protein. Proc Natl Acad Sci 100:3263–8.
105. M.Karin, Y.Ben-Neriah (2000). Phosphorylation meets ubiquitination:the control of NF-κB activity. Annu Rev Immunol 18:621–63.
106. F.Khanim, C.Dawson, C.A.Meseda, et al. (1997). BHRF1, a viral homolog of the Bcl-2 oncogene, is conserved at both the sequence and functional level in different Epstein–Barr virus isolates. J Gen Virol 78:2987–99.
107. F.C.Kischkel, S.Hellbardt, I.Behrmann, et al. (1995). Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J 14:5579–88.
108. T.N.Kledal, M.M.Rosenkilde, F.Coulin, et al. (1997). A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus. Science 277:1656–9.
109. S.V.Kotenko, S.Saccani, L.S.Izotova, et al. (2000). Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). Proc Natl Acad Sci 97:1695–700.
110. P.Krajcsi, T.Dimitrov, T.W.Hermiston, et al. (1996). The adenovirus E3-14.7K protein and the E3-10.4K/14.5K complex of proteins, which independently inhibit tumor necrosis factor (TNF)-induced apoptosis, also independently inhibit TNF-induced release of arachidonic acid. J Virol 70:4904–13.
111. F.Kratzer, O.Rosorius, P.Heger, et al. (2000). The adenovirus type 5 E1B-55K oncoprotein is a highly active shuttle protein and shuttling is independent of E4orf6, p53 and Mdm2. Oncogene 19:850–7.
112. B.Krumm, X.Meng, Y.Li, et al. (2008). Structural basis for antagonism of human interleukin 18 by poxvirus interleukin 18-binding protein. Proc Natl Acad Sci 105:20711–15.
113. E.A.Kurt-Jones, M.Chan, S.Zhou, et al. (2004). Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc Natl Acad Sci USA 101:1315–20.
114. A.D.Kwong, N.Frenkel (1987). Herpes-simplex virus-infected cells contain a function(S) that destabilizes both host and viral messenger-Rnas. Proc Natl Acad Sci USA 84:1926–30.
115. K.S.Lang, A.Burow, M.Kurrer, et al. (2007). The role of the innate immune response in autoimmune disease. J Autoimmunity 29:206–12.
116. K.G.Laing, V.Matys, M.J.Clemens (2001). Analysis of the expression and function of the EBV-encoded small RNAs, the EBERs, in heterologous cells. Methods Mol Biol 174:45–66.
117. M.Lamkanfi, V.M.Dixit (2014). Mechanisms and functions of inflammasomes. Cell 157:1013–22.
118. J.O.Langland, J.M.Cameron, M.C.Heck, et al. (2006). Inhibition of PKR by RNA and DNA viruses. Virus Res 119:100–10.
119. L.Lau, E.E.Gray, R.L.Brunet, D.B.Stetson (2015). DNA tumor virus oncogenes antagonize the cGAS-STING DNA-sensing pathway. Science 350:568–71.
120. K.Launer-Felty, C.J.Wong, J.L.Cole (2015). Structural analysis of adenovirus VAI RNA defines the mechanism of inhibition of PKR. Biophys J 108:748–57.
121. S.H.Lecker, A.L.Goldberg, W.E.Mitch (2006). Protein degradation by the ubiquitin–proteasome pathway in normal and disease states. J Am Soc Nephrol 17:1807–19.
122. H.-R.Lee, S.Doğanay, B.Chung, et al. (2014). Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 4 (vIRF4) targets expression of cellular IRF4 and the Myc gene to facilitate lytic replication. J Virol 88:2183–94.
123. H.R.Lee, D.J.Kim, J.M.Lee, et al. (2004). Ability of the human cytomegalovirus IE1 protein to modulate sumoylation of PML correlates with its functional activities in transcriptional regulation and infectivity in cultured fibroblast cells. J Virol 78:6527–42.
124. S.P.Lees-Miller, M.C.Long, M.A.Kilvert, et al. (1996). Attenuation of DNA-dependent protein kinase activity and its catalytic subunit by the herpes simplex virus type 1 transactivator ICP0. J Virol 70:7471–7.
125. S.Lefort, A.Soucy-Faulkner, N.Grandvaux, L.Flamand (2007). Binding of Kaposi's sarcoma-associated herpesvirus K-bZIP to interferon-responsive factor 3 elements modulates antiviral gene expression. J Virol 81:10950–60.
126. Q.Li, R.Means, S.Lang, J.U.Jung (2007). Downregulation of gamma interferon receptor 1 by Kaposi's sarcoma-associated herpesvirus K3 and K5. J Virol 81:2117–27.
127. T.Li, J.Chen, I.M.Cristea (2013). Human cytomegalovirus tegument protein pUL83 inhibits IFI16-mediated DNA sensing for immune evasion. Cell Host Microbe 14:591–9.
128. Q.Liang, B.Fu, F.Wu, et al. (2012). ORF45 of Kaposi's sarcoma-associated herpesvirus inhibits phosphorylation of interferon regulatory factor 7 by IKKɛ and TBK1 as an alternative substrate. J Virol 86:10162–72.
129. M.R.Lieber, Y.Ma, U.Pannicke, K.Schwarz (2003). Mechanism and regulation of human non-homologous DNA end-joining. Nat Rev Mol Cell Biol 4:712–20.
130. P.M.Lieberman (2016). Epigenetics and genetics of viral latency. Cell Host Microbe 19:619–28.
131. A.E.Lin, T.M.Greco, K.Döhner, et al. (2013). A proteomic perspective of inbuilt viral protein regulation:pUL46 tegument protein is targeted for degradation by ICP0 during herpes simplex virus type 1 infection. Mol Cell Proteomics:MCP 12:3237–52.
132. H.W.Lin, Y.Y.Chang, M.L.Wong, et al. (2004). Functional analysis of virion host shutoff protein of pseudorabies virus. Virology 324:412–18.
133. R.Lin, P.Genin, Y.Mamane, et al. (2001). HHV-8 encoded vIRF-1 represses the interferon antiviral response by blocking IRF-3 recruitment of the CBP/p300 coactivators. Oncogene 20:800–11.
134. P.D.Ling, J.Tan, J.Sewatanon, R.Peng (2008). Murine gammaherpesvirus 68 open reading frame 75c tegument protein induces the degradation of PML and is essential for production of infectious virus. J Virol 82:8000–12.
135. Y.Liu, R.de Waal Malefyt, F.Briere, et al. (1997). The EBV IL-10 homolog is a selective agonist with impaired binding to the IL-10 receptor. J Immunol 158:604–13.
136. A.K.F.Lo, K.F.To, K.W.Lo, et al. (2007). Modulation of LMP1 protein expression by EBV-encoded microRNAs. P Natl Acad Sci USA 104:16164–9.
137. R.M.Locksley, N.Killeen, M.J.Lenardo (2001). The TNF and TNF receptor superfamilies:integrating mammalian biology. Cell 104:487–501.
138. V.N.Loparev, J.M.Parsons, J.C.Knight, et al. (1998). A third distinct tumor necrosis factor receptor of orthopoxviruses. Proc Natl Acad Sci USA A 95:3786–91.
139. V.Lukashchuk, S.McFarlane, R.D.Everett, C.M.Preston (2008). Human cytomegalovirus protein pp71 displaces the chromatin-associated factor ATRX from nuclear domain 10 at early stages of infection. J Virol 82:12543–54.
140. J.Ma, F.Edlich, G.A.Bermejo, et al. (2012). Structural mechanism of Bax inhibition by cytomegalovirus protein vMIA. Proc Natl Acad Sci USA 109:20901–6.
141. L.Marcos-Villar, F.Lopitz-Otsoa, P.Gallego, et al. (2009). Kaposi's sarcoma-associated herpesvirus protein LANA2 disrupts PML oncogenic domains and inhibits PML-mediated transcriptional repression of the survivin gene. J Virol 83:8849–58.
142. I.Marié, E.Smith, A.Prakash, D.E.Levy (2000). Phosphorylation-induced dimerization of interferon regulatory factor 7 unmasks DNA binding and a bipartite transactivation domain. Mol Cell Biol 20:8803–14.
143. E.E.Marshall, C.J.Bierle, W.Brune, A.P.Geballe (2009). Essential role for either TRS1 or IRS1 in human cytomegalovirus replication. J Virol 83:4112–20.
144. W.L.Marshall, C.Yim, E.Gustafson, et al. (1999). Epstein–Barr virus encodes a novel homolog of the bcl-2 oncogene that inhibits apoptosis and associates with Bax and Bak. J Virol 73:5181–5.
145. M.E.D.Martin, A.J.Berk (1998). Adenovirus E1B 55K represses p53 activation in vitro. J Virol 72:3146–54.
146. H.Matta, L.Mazzacurati, S.Schamus, et al. (2007). Kaposi's sarcoma-associated herpesvirus (KSHV) oncoprotein K13 bypasses TRAFs and directly interacts with the I kappa B kinase complex to selectively activate NF-kappa B without JNK activation. J Biol Chem 282:24858–65.
147. W.P.Mboko, H.Olteanu, A.Ray, et al. (2016). Tumor suppressor interferon-regulatory factor 1 counteracts the germinal center reaction driven by a cancer-associated gammaherpesvirus. J Virol 90:2818–29.
148. A.L.McCormick, L.Roback, D.Livingston-Rosanoff, C.St Clair (2010). The human cytomegalovirus UL36 gene controls caspase-dependent and -independent cell death programs activated by infection of monocytes differentiating to macrophages. J Virol 84:5108–23.
149. B.P.McSharry, S.Avdic, B.Slobedman (2012). Human cytomegalovirus encoded homologs of cytokines, chemokines and their receptors:roles in immunomodulation. Viruses 4:2448–70.
150. G.T.Melroe, L.Silva, P.A.Schaffer, D.M.Knipe (2007). Recruitment of activated IRF-3 and CBP/p300 to herpes simplex virus ICP0 nuclear foci:potential role in blocking IFN-beta induction. Virology 360:305–21.
151. X.Meng, M.Leman, Y.Xiang (2007). Variola virus IL-18 binding protein interacts with three human IL-18 residues that are part of a binding site for human IL-18 receptor alpha subunit. Virology 358:211–20.
152. J.Mi, Z.Y.Li, S.Ni, et al. (2001). Induced apoptosis supports spread of adenovirus vectors in tumors. Hum Gene Ther 12:1343–52.
153. D.M.Miller, B.M.Rahill, J.M.Boss, et al. (1998). Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway. J Exp Med 187:675–83.
154. L.K.Miller (1997). Baculovirus interaction with host apoptotic pathways. J Cell Physiol 173:178–82.
155. A.M.Mitchell, M.L.Hirsch, C.Li, R.J.Samulski (2014). Promyelocytic leukemia protein is a cell-intrinsic factor inhibiting parvovirus DNA replication. J Virol 88:925–36.
156. T.Miyashita, S.Krajewski, M.Krajewska, et al. (1994). Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9:1799–805.
157. J.Molden, Y.Chang, Y.You, et al. (1997). A Kaposi’s sarcoma-associated herpesvirus-encoded cytokine homolog (vIL-6) activates signaling through the shared gp130 receptor subunit. J Biol Chem 272:19625–31.
158. P.S.Moore, C.Boshoff, R.A.Weiss, Y.Chang (1996). Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science 274:1739–44.
159. H.Moriuchi, M.Moriuchi, H.A.Smith, et al. (1992). Varicella-zoster virus open reading frame 61 protein is functionally homologous to herpes simplex virus type 1 ICP0. J Virol 66:7303–8.
160. J.Munger, R.Hagglund, B.Roizman (2003). Infected cell protein No. 22 is subject to proteolytic cleavage by caspases activated by a mutant that induces apoptosis. Virology 305:364–70.
161. J.A.Murphy, R.J.Duerst, T.J.Smith, L.A.Morrison (2003). Herpes simplex virus type 2 virion host shutoff protein regulates alpha/beta interferon but not adaptive immune responses during primary infection in vivo. J Virol 77:9337–45.
162. M.Mutocheluh, L.Hindle, C.Aresté, et al. (2011). Kaposi’s sarcoma-associated herpesvirus viral interferon regulatory factor-2 inhibits type 1 interferon signaling by targeting interferon-stimulated gene factor-3. J Gen Virol 92:2394–8.
163. V.E.Nava, E.H.Cheng, M.Veliuona, et al. (1997). Herpesvirus saimiri encodes a functional homolog of the human bcl-2 oncogene. J Virol 71:4118–22.
164. F.Neipel, J.C.Albrecht, A.Ensser, et al. (1997). Human herpesvirus 8 encodes a homolog of interleukin-6. J Virol 71:839–42.
165. M.Niebler, X.Qian, D.Höfler, et al. (2013). Post-translational control of IL-1? via the human papillomavirus type 16 E6 oncoprotein:a novel mechanism of innate immune escape mediated by the E3-ubiquitin ligase E6-AP and p53. PLoS Pathog 9:e1003536.
166. G.Niedobitek, L.S.Young, R.Lau, et al. (1991). Epstein–Barr virus infection in oral hairy leukoplakia:virus replication in the absence of a detectable latent phase. J Gen Virol 72:3035–46.
167. M.L.Nogal, G.Gonzalez de Buitrago, C.Rodriguez, et al. (2001). African swine fever virus IAP homolog inhibits caspase activation and promotes cell survival in mammalian cells. J Virol 75:2535–43.
168. H.Nozawa, E.Oda, K.Nakao, et al. (1999). Loss of transcription factor IRF-1 affects tumor susceptibility in mice carrying the Ha-ras transgene or nullizygosity for p53. Genes Dev 13:1240–5.
169. Z.N.Oltvai, C.L.Milliman, S.J.Korsmeyer (1993). Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death. Cell 74:609–19.
170. A.A.Oroskar, G.S.Read (1987). A mutant of herpes-simplex virus type-1 exhibits increased stability of immediate-early (Alpha) messenger-Rnas. J Virol 61:604–6.
171. A.A.Oroskar, G.S.Read (1989). Control of messenger-Rna stability by the virion host shutoff function of herpes-simplex virus. J Virol 63:1897–906.
172. M.H.Orzalli, N.A.DeLuca, D.M.Knipe (2012). Nuclear IFI16 induction of IRF-3 signaling during herpesviral infection and degradation of IFI16 by the viral ICP0 protein. Proc Natl Acad Sci USA 109:E3008–17.
173. J.S.Park, E.J.Kim, H.J.Kwon, et al. (2000). Inactivation of interferon regulatory factor-1 tumor suppressor protein by HPV E7 oncoprotein – implication for the E7-mediated immune evasion mechanism in cervical carcinogenesis. J Biol Chem 275:6764–9.
174. J.Parkinson, S.P.Lees-Miller, R.D.Everett (1999). Herpes simplex virus type 1 immediate-early protein Vmw110 induces the proteasome-dependent degradation of the catalytic subunit of DNA-dependent protein kinase. J Virol 73:650–7.
175. S.Parrish, B.Moss (2007). Characterization of a second vaccinia virus mRNA-decapping enzyme conserved in poxviruses. J Virol 81:12973–8.
176. S.Parrish, W.Resch, B.Moss (2007). Vaccinia virus D10 protein has mRNA decapping activity, providing a mechanism for control of host and viral gene expression. Proc Natl Acad Sci USA 104:2139–44.
177. T.J.Pasieka, B.Lu, S.D.Crosby, et al. (2008). Herpes simplex virus virion host shutoff attenuates establishment of the antiviral state. J Virol 82:5527–35.
178. S.J.Paulsen, M.M.Rosenkilde, J.Eugen-Olsen, T.N.Kledal (2005). Epstein–Barr virus-encoded BILF1 is a constitutively active G protein-coupled receptor. J Virol 79:536–46.
179. G.A.Peters, D.Khoo, I.Mohr, G.C.Sen (2002). Inhibition of PACT-mediated activation of PKR by the herpes simplex virus type 1 Us11 protein. J Virol 76:11054–64.
180. A.C.Pezda, A.Penn, G.M.Barton, L.Coscoy (2011). Suppression of TLR9 immunostimulatory motifs in the genome of a gammaherpesvirus. J Immunol 187:887–96.
181. S.Pflanz, J.C.Timans, J.Cheung, et al. (2002). IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells. Immunity 16:779–90.
182. A.P.Poon, H.Gu, B.Roizman (2006). ICP0 and the US3 protein kinase of herpes simplex virus 1 independently block histone deacetylation to enable gene expression. Proc Natl Acad Sci USA 103:9993–8.
183. A.Prakash, D.E.Levy (2006). Regulation of IRF7 through cell type-specific protein stability. Biochem Biophys Res Co 342:50–6.
184. Z.Q.Qin, P.Kearney, K.Plaisance, C.H.Parsons (2010). Kaposi's sarcoma-associated herpesvirus (KSHV)-encoded microRNA specifically induce IL-6 and IL-10 secretion by macrophages and monocytes. J Leukocyte Biol 87:25–34.
185. F.Randow, P.J.Lehner (2009). Viral avoidance and exploitation of the ubiquitin system. Nat Cell Biol 11:527–34.
186. L.Rao, M.Debbas, P.Sabbatini, et al. (1992). The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins. Proc Natl Acad Sci USA 89:7742–6.
187. L.Rao, D.Modha, E.White (1997). The E1B 19K protein associates with lamins in vivo and its proper localization is required for inhibition of apoptosis. Oncogene 15:1587–97.
188. G.S.Read, N.Frenkel (1983). Herpes-simplex virus mutants defective in the virion-associated shutoff of host polypeptide-synthesis and exhibiting abnormal synthesis of alpha-(immediate early) viral polypeptides. J Virol 46:498–512.
189. P.C.Reading, G.L.Smith (2003). Vaccinia virus interleukin-18-binding protein promotes virulence by reducing gamma interferon production and natural killer and T-cell activity. J Virol 77:9960–8.
190. M.B.Reeves, A.A.Davies, B.P.McSharry, et al. (2007). Complex I binding by a virally encoded RNA regulates mitochondria-induced cell death. Science 316:1345–8.
191. S.J.Riedl, Y.Shi (2004). Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Biol 5:897–907.
192. H.G.Rivas, S.K.Schmaling, M.M.Gaglia (2016). Shutoff of host gene expression in influenza A virus and herpesviruses:similar mechanisms and common themes. Viruses 8:1–26.
193. K.L.Rock, C.Gramm, L.Rothstein, et al. (1994). Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78:761–71.
194. L.V.Ronco, A.Y.Karpova, M.Vidal, P.M.Howley (1998). Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. Genes Dev 12:2061–72.
195. A.Roulston, R.C.Marcellus, P.E.Branton (1999). Viruses and apoptosis. Annu Rev Microbiol 53:577–628.
196. M.Rowe, B.Glaunsinger, D.van Leeuwen, et al. (2007). Host shutoff during productive Epstein-Barr virus infection is mediated by BGLF5 and may contribute to immune evasion. P Natl Acad Sci USA 104:3366–71.
197. R.T.Saffert, R.F.Kalejta (2006). Inactivating a cellular intrinsic immune defense mediated by Daxx is the mechanism through which the human cytomegalovirus pp71 protein stimulates viral immediate-early gene expression. J Virol 80:3863–71.
198. N.K.Sah, T.K.Taneja, N.Pathak, et al. (1999). The baculovirus antiapoptotic p35 gene also functions via an oxidant-dependent pathway. Proc Natl Acad Sci USA 96:4838–43.
199. B.Sainz, H.L.LaMarca, R.F.Garry, C.A.Morris (2005). Synergistic inhibition of human cytomegalovirus replication by interferon-alpha/beta and interferon-gamma. Virol J 2:14.
200. K.Saira, Y.Zhou, C.Jones (2007). The infected cell protein 0 encoded by bovine herpesvirus 1 (bICP0) induces degradation of interferon response factor 3 and, consequently, inhibits beta interferon promoter activity. J Virol 81:3077–86.
201. H.Sato, L.D.Callanan, L.Pesnicak, et al. (2002). Varicella-zoster virus (VZV) ORF17 protein induces RNA cleavage and is critical for replication of VZV at 37 degrees C but not 33 degrees C. J Virol 76:11012–23.
202. D.Savitsky, T.Tamura, H.Yanai, T.Taniguchi (2010). Regulation of immunity and oncogenesis by the IRF transcription factor family. Cancer Immunol Immun 59:489–510.
203. M.Scheffner, B.A.Werness, J.M.Huibregtse, et al. (1990). The E6 oncoprotein encoded by human papillomavirus type-16 and type-18 promotes the degradation of P53. Cell 63:1129–36.
204. N.Schek, S.L.Bachenheimer (1985). Degradation of cellular messenger-Rnas induced by a virion-associated factor during herpes-simplex virus-infection of vero cells. J Virol 55:601–10.
205. J.Scheller, A.Chalaris, D.Schmidt-Arras, S.Rose-John (2011). The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta (BBA) - Mol Cell Res 1813:878–88.
206. M.Scherer, T.Stamminger (2016). Gem:emerging role of PML nuclear bodies in innate immune signaling. J Virol 90:5850–5854.
207. J.Schott, G.Stoecklin (2010). Networks controlling mRNA decay in the immune system. Wires Rna 1:432–56.
208. S.Schreiner, P.Wimmer, H.Sirma, et al. (2010). Proteasome-dependent degradation of Daxx by the viral E1B-55K protein in human adenovirus-infected cells. J Virol 84:7029–38.
209. M.Schroder, M.Baran, A.G.Bowie (2008). Viral targeting of human DEAD-box protein 3 reveals its novel role in IRF3/7 activation. Cytokine 43:313.
210. K.B.Schwarz (1996). Oxidative stress during viral infection:a review. Free Radical Bio Med 21:641–9.
211. G.H.Shen, K.Z.Wang, S.Wang, et al. (2014). Herpes simplex virus 1 counteracts viperin via its virion host shutoff protein UL41. J Virol 88:12163–6.
212. Y.Shen, T.E.Shenk (1995). Viruses and apoptosis. Curr Opin Genet Dev 5:105–11.
213. Y.Shi (2002). Mechanisms of caspase activation and inhibition during apoptosis. Mol Cell 9:459–70.
214. J.Shisler, C.Yang, B.Walter, et al. (1997). The adenovirus E3-10.4K/14.5K complex mediates loss of cell surface Fas (CD95) and resistance to Fas-induced apoptosis. J Virol 71:8299–306.
215. J.L.Shisler, B.Moss (2001). Molluscum contagiosum virus inhibitors of apoptosis:the MC159 v-FLIP protein blocks Fas-induced activation of procaspases and degradation of the related MC160 protein. Virology 282:14–25.
216. J.L.Shisler, T.G.Senkevich, M.J.Berry, B.Moss (1998). Ultraviolet-induced cell death blocked by a selenoprotein from a human dermatotropic poxvirus. Science 279:102–5.
217. M.F.Shu, B.Taddeo, B.Roizman (2015). Tristetraprolin recruits the herpes simplex virion host shutoff RNase to AU-rich elements in stress response mRNAs to enable their cleavage. J Virol 89:5643–50.
218. N.Sivachandran, X.Wang, L.Frappier (2012). Functions of the Epstein–Barr virus EBNA1 protein in viral reactivation and lytic infection. J Virol 86:6146–58.
219. E.Sloan, M.H.Tatham, M.Groslambert, et al. (2015). Analysis of the SUMO2 proteome during HSV-1 infection. PLoS Pathog 11:e1005059.
220. J.R.Smiley, M.M.Elgadi, H.A.Saffran (2001). Herpes simplex virus vhs protein. Method Enzymol 342:440–51.
221. C.A.Smith, F.Q.Hu, T.D.Smith, et al. (1996). Cowpox virus genome encodes a second soluble homolog of cellular TNF receptors, distinct from CrmB, that binds TNF but not LT alpha. Virology 223:132–47.
222. G.L.Smith, Y.S.Chan (1991). Two vaccinia virus proteins structurally related to the interleukin-1 receptor and the immunoglobulin superfamily. J Gen Virol 72:511–18.
223. K.J.Smith, J.Yeager, H.Skelton (1999). Molluscum contagiosum:its clinical, histopathologic, and immunohistochemical spectrum. Int J Dermatol 38:664–72.
224. V.P.Smith, N.A.Bryant, A.Alcamı´ (2000). Ectromelia, vaccinia and cowpox viruses encode secreted interleukin-18-binding proteins. J Gen Virol 81:1223–30.
225. W.Smith, P.Tomasec, R.Aicheler, et al. (2013). Human cytomegalovirus glycoprotein UL141 targets the TRAIL death receptors to thwart host innate antiviral defenses. Cell Host Microbe 13:324–35.
226. D.Soulat, T.Buerckstuemmer, S.Westermayer, et al. (2008). The DEAD-box helicase DDX3X is a critical component of the TANK-binding kinase 1-dependent innate immune response. Wien Klin Wochenschr 120:21
227. J.V.Spencer, K.M.Lockridge, P.A.Barry, et al. (2002). Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10. J Virol 76:1285–92.
228. M.K.Spriggs, D.E.Hruby, C.R.Maliszewski, et al. (1992). Vaccinia and cowpox viruses encode a novel secreted interleukin-1-binding protein. Cell 71:145–52.
229. J.Stack, I.R.Haga, M.Schroder, et al. (2005). Vaccinia virus protein Toll-like-interleukin-1 A46R targets multiple receptor adaptors and contributes to virulence. J Exp Med 201:1007–18.
230. W.H.Stepp, J.M.Meyers, A.A.McBride (2013). Sp100 provides intrinsic immunity against human papillomavirus infection. mBio 4. e00845-13
231. N.Stern-Ginossar, N.Elefant, A.Zimmermann, et al. (2007). Host immune system gene targeting by a viral miRNA. Science 317:376–81.
232. R.Stienstra, L.A.B.Joosten, T.Koenen, et al. (2010). The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity. Cell Metab 12:593–605.
233. T.H.Stracker, C.T.Carson, M.D.Weitzman (2002). Adenovirus oncoproteins inactivate the Mre11-Rad50-NBS1 DNA repair complex. Nature 418:348–52.
234. A.Strasser, D.C.Huang, D.L.Vaux (1997). The role of the bcl-2/ced-9 gene family in cancer and general implications of defects in cell death control for tumourigenesis and resistance to chemotherapy. Biochim Biophys Acta 1333:F151–78.
235. C.H.Su, J.Zhang, C.F.Zheng (2015). Herpes simplex virus 1 UL41 protein abrogates the antiviral activity of hZAP by degrading its mRNA. Virol J 12:203
236. N.Sunthamala, F.Thierry, S.Teissier, et al. (2014). E2 proteins of high risk human papillomaviruses down-modulate STING and IFN-kappa transcription in keratinocytes. PLoS One 9:e0091473
237. S.A.Susin, H.K.Lorenzo, N.Zamzami, et al. (1999). Mitochondrial release of caspase-2 and -9 during the apoptotic process. J Exp Med 189:381–94.
238. S.Swaminathan, R.Hesselton, J.Sullivan, E.Kieff (1993). Epstein–Barr virus recombinants with specifically mutated BCRF1 genes. J Virol 67:7406–13.
239. S.W.G.Tait, E.B.Reid, D.R.Greaves, et al. (2000). Mechanism of inactivation of NF-kappa B by a viral homolog of I kappa B alpha – signal-induced release of I kappa B alpha results in binding of the viral homolog to NF-kappa B. J Biol Chem 275:34656–64.
240. R.T.Taylor, W.A.Bresnahan (2005). Human cytomegalovirus immediate-early 2 gene expression blocks virus-induced beta interferon production. J Virol 79:3873–7.
241. R.T.Taylor, W.A.Bresnahan (2006). Human cytomegalovirus IE86 attenuates virus-and tumor necrosis factor alpha-induced NFkappaB-dependent gene expression. J Virol 80:10763–71.
242. J.G.Teodoro, P.E.Branton (1997). Regulation of apoptosis by viral gene products. J Virol 71:1739–46.
243. M.R.Thompson, J.J.Kaminski, E.A.Kurt-Jones, K.A.Fitzgerald (2011). Pattern recognition receptors and the innate immune response to viral infection. Viruses 3:920–40.
244. N.A.Thornberry, Y.Lazebnik (1998). Caspases:enemies within. Science 281:1312–16.
245. B.Tolani, H.Matta, R.Gopalakrishnan, et al. (2014). NEMO is essential for Kaposi's sarcoma-associated herpesvirus-encoded vFLIP K13-induced gene expression and protection against death receptor-induced cell death, and its N-terminal 251 residues are sufficient for this process. J Virol 88:6345–54.
246. B.Tummers, R.Goedemans, L.P.Pelascini, et al. (2015). The interferon-related developmental regulator 1 is used by human papillomavirus to suppress NFkappaB activation. Nat Commun 6:6537.
247. S.J.Um, J.W.Rhyu, E.J.Kim, et al. (2002). Abrogation of IRF-1 response by high-risk HPV E7 protein in vivo. Cancer Lett 179:205–12.
248. L.Unterholzner, A.G.Bowie (2008). The interplay between viruses and innate immune signaling:recent insights and therapeutic opportunities. Biochem Pharmacol 75:589–602.
249. J.W.Upton, W.J.Kaiser, E.S.Mocarski (2010). Virus inhibition of RIP3-dependent necrosis. Cell Host Microbe 7:302–13.
250. J.W.Upton, W.J.Kaiser, E.S.Mocarski (2012). DAI complexes with RIP3 to mediate virus-induced programed necrosis that is targeted by murine cytomegalovirus vIRA. Cell Host Microbe 11:290–7.
251. A.L.van Lint, M.R.Murawski, R.E.Goodbody, et al. (2010). Herpes simplex virus immediate-early ICP0 protein inhibits Toll-like receptor 2-dependent inflammatory responses and NF-κB signaling. J Virol 84:10802–11.
252. S.M.Varnum, D.N.Streblow, M.E.Monroe, et al. (2004). Identification of proteins in human cytomegalovirus (HCMV) particles:the HCMV proteome. J Virol 78:13395.
253. D.Verpooten, Y.J.Ma, S.W.Hou, et al. (2009). Control of TANK-binding kinase 1-mediated signaling by the gamma(1)34.5 protein of herpes simplex virus 1. J Biol Chem 284:1097–105.
254. P.Vieira, R.de Waal-Malefyt, M.N.Dang, et al. (1991). Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones:homology to Epstein–Barr virus open reading frame BCRFI. Proc Natl Acad Sci USA 88:1172–6.
255. C.von Roretz, S.Di Marco, R.Mazroui, I.E.Gallouzi (2011). Turnover of AU-rich-containing mRNAs during stress:a matter of survival. Wires Rna 2:336–47.
256. M.Vuyisich, R.J.Spanggord, P.A.Beal (2002). The binding site of the RNA-dependent protein kinase (PKR) on EBER1 RNA from Epstein–Barr virus. EMBO Rep 3:622–7.
257. N.Wagenknecht, N.Reuter, M.Scherer, et al. (2015). Contribution of the major ND10 proteins PML, hDaxx and Sp100 to the regulation of human cytomegalovirus latency and lytic replication in the monocytic cell line THP-1. Viruses 7:2751.
258. M.S.Walters, A.Erazo, P.R.Kinchington, S.Silverstein (2009). Histone deacetylases 1 and 2 are phosphorylated at novel sites during varicella-zoster virus infection. J Virol 83:11502–13.
259. M.S.Walters, P.R.Kinchington, B.W.Banfield, S.Silverstein (2010). Hyperphosphorylation of histone deacetylase 2 by alphaherpesvirus US3 kinases. J Virol 84:9666–76.
260. G.H.Wang, J.Bertin, Y.Wang, et al. (1997). Bovine herpesvirus 4 BORFE2 protein inhibits Fas- and tumor necrosis factor receptor 1-induced apoptosis and contains death effector domains shared with other gamma-2 herpesviruses. J Virol 71:8928–32.
261. K.Wang, L.Ni, S.Wang, C.Zheng (2014). Herpes simplex virus 1 protein kinase US3 hyperphosphorylates p65/RelA and dampens NF-kappaB activation. J Virol 88:7941–51.
262. S.Wang, K.Wang, R.Lin, C.Zheng (2013). Herpes simplex virus 1 serine/threonine kinase US3 hyperphosphorylates IRF3 and inhibits beta interferon production. J Virol 87:12814–27.
263. M.D.Weiden, H.S.Ginsberg (1994). Deletion of the E4 region of the genome produces adenovirus DNA concatemers. Proc Natl Acad Sci USA 91:153–7.
264. M.D.Weitzman, C.E.Lilley, M.S.Chaurushiya (2010). Genomes in conflict:maintaining genome integrity during virus infection. Annu Rev Microbiol 64:61–81.
265. M.D.Weitzman, D.A.Ornelles (2005). Inactivating intracellular antiviral responses during adenovirus infection. Oncogene 24:7686–96.
266. M.S.Wiebe, P.Traktman (2007). Barrier to autointegration factor is a host defense against poxvirus replication that is overcome by the viral B1 kinase. Cell Host Microbe 1:187–97.
267. E.Wies, A.S.Hahn, K.Schmidt, et al. (2009). The Kaposi's sarcoma-associated herpesvirus-encoded vIRF-3 inhibits cellular IRF-5. J Biol Chem 284:8525–38.
268. B.R.G.Williams (1995). The role of the dsRNA-activated kinase, PKR, in signal transduction. Semin Virol 6:191–202.
269. J.J.Wu, W.W.Li, Y.M.Shao, et al. (2015). Inhibition of cGAS DNA sensing by a herpesvirus virion protein. Cell Host Microbe 18:333–44.
270. Y.Xiang, B.Moss (2001). Correspondence of the functional epitopes of poxvirus and human interleukin-18-binding proteins. J Virol 75:9947–54.
271. J.J.Xing, L.W.Ni, S.Wang, et al. (2013). Herpes simplex virus 1-encoded tegument protein VP16 abrogates the production of beta interferon (IFN) by inhibiting NF-kappa B activation and blocking IFN regulatory factor 3 to recruit its coactivator CBP. J Virol 87:9788–801.
272. R.Yamin, N.S.Kaynan, A.Glasner, et al. (2013). The viral KSHV chemokine vMIP-II inhibits the migration of naive and activated human NK cells by antagonizing two distinct chemokine receptors. PLoS Pathog 9:e1003568.
273. N.Yanai, M.Obinata (1994). Apoptosis is induced at nonpermissive temperature by a transient increase in P53 in cell-lines immortalized with temperature-sensitive Sv40 large T-antigen gene. Exp Cell Res 211:296–300.
274. M.You, D.H.Yu, G.S.Feng (1999). Shp-2 tyrosine phosphatase functions as a negative regulator of the interferon-stimulated Jak/STAT pathway. Mol Cell Biol 19:2416–24.
275. Y.J.Yu, J.C.Alwine (2006). 19S Late mRNAs of simian virus 40 have an internal ribosome entry site upstream of the virion structural protein 3 coding sequence. J Virol 80:6553–8.
276. Y.X.Yu, S.Z.E.Wang, G.S.Hayward (2005). The KSHV immediate-early transcription factor RTA encodes ubiquitin E3 ligase activity that targets IRF7 for proteosome-mediated degradation. Immunity 22:59–70.
277. J.Zhang, K.Wang, S.Wang, C.Zheng (2013). Herpes simplex virus 1 E3 ubiquitin ligase ICP0 protein inhibits tumor necrosis factor alpha-induced NF-κB activation by interacting with p65/RelA and p50/NF-κB1. J Virol 87:12935–48.
278. H.Zhu, C.Zheng, J.Xing, et al. (2011). Varicella-zoster virus immediate-early protein ORF61 abrogates the IRF3-mediated innate immune response through degradation of activated IRF3. J Virol 85:11079–89.
279. J.C.Zimring, S.Goodbourn, M.K.Offermann (1998). Human herpesvirus 8 encodes an interferon regulatory factor (IRF) homolog that represses IRF-1-mediated transcription. J Virol 72:701–7.
280. D.Zipeto, B.Bodaghi, L.Laurent, et al. (1999). Kinetics of transcription of human cytomegalovirus chemokine receptor US28 in different cell types. J Gen Virol 80:543–7.